for the following products
2-(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid | MRE-269 | [4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-acetic acid and Selexipag Active Metabolite (ACT-333679)
We are one of the world leading companies in manufacturing pharmaceutical standards, including stable-isotope labeled internal standards, metabolites, degradation compounds/impurities, and inhibitor reference compounds. Our products are widely used in Bioanalysis (BA) for preclinical/early stage clinical studies and Bioequivalence (BE) studies for generic drug development.
